Acasti Pharma Stock Price - ACST

-0.0031 (-0.72%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Acasti Pharma Inc ACST NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.0165 -3.71% 0.4281 0.40 0.4341 0.40 0.4446 00:00:00
Bid Price Ask Price Spread Spread % News
0.425 0.4699 0.0449 9.56% 1 1
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,292 1,363,891 $ 0.4200762 $ 572,938 6,026,338 0.40 - 3.08
Last Trade Time Type Quantity Stock Price Currency
19:37:34 16 $ 0.425 USD

Acasti Pharma Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 38.62M 90.21M $ -21.50M - - 90.21M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Acasti Pharma News

Loading Messages....

Latest ACST Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ACST Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.580.580.400.48586611,767,788-0.1519-26.19%
1 Month0.700.870.400.63638273,839,158-0.2719-38.84%
3 Months1.903.080.401.355,300,434-1.47-77.47%
6 Months1.653.080.401.523,148,699-1.22-74.05%
1 Year1.053.080.401.592,206,049-0.6219-59.23%
3 Years1.193.35650.401.511,009,104-0.7619-64.03%
5 Years6.1016.1010.31351.56644,242-5.67-92.98%

Acasti Pharma Description

Acasti Pharma Inc is a biopharmaceutical company operating in Canada. It focuses on the research, development, and commercialization of prescription drugs using omega-3 fatty acids derived from krill oil. The key product candidate of the company, CaPre is developed for the treatment of severe hypertriglyceridemia, which is a condition characterized by abnormally high levels of triglycerides in the bloodstream. Its only operating segment being the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases.

Your Recent History
Acasti Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.